ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models-Reference-Cited by-同舟云学术

ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models

Published:2019-09-19 Issue:18 Volume:4 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Wallstabe Lars^ORCID,Göttlich Claudia,Nelke Lena C.,Kühnemundt Johanna^ORCID,Schwarz Thomas,Nerreter Thomas^ORCID,Einsele Hermann^ORCID,Walles Heike,Dandekar Gudrun^ORCID,Nietzer Sarah L.,Hudecek Michael^ORCID

Funder

Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg

Deutsche Krebshilfe

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/126345/files/pdf

Reference44 articles.

1. CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

2. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

3. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

4. The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor

5. Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies;Recent Patents on Anti-Cancer Drug Discovery;2024-12

2. Human breast tissue engineering in health and disease;EMBO Molecular Medicine;2024-08-23

3. Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies;Science China Life Sciences;2024-08-12

4. Extracellular domain, hinge, and transmembrane determinants affecting surface CD4 expression of a novel anti-HIV chimeric antigen receptor (CAR) construct;PLOS ONE;2024-08-12

5. CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy;Scientific Reports;2024-08-02